Aptamil Stage 1 Infant Formula with DHA, Omega 3 & Prebiotics 1.76 Pounds

Aptamil Stage 1, No. 1 Baby Formula in Europe is a carefully crafted milk-based powder infant formula designed to provide essential nutrients for your baby's healthy growth and development. This premium formula is suitable for infants from birth onwards and comes in a convenient 1.76-pound (800g) pack. It is formulated with key ingredients such as DHA, Omega-3 fatty acids, and prebiotics to support your baby's overall well-being.

Features:

• Suitable from Birth: Aptamil Stage 1 is suitable for newborns and can be used as a complete substitute for or in combination with breast milk, as recommended by healthcare professionals.
• Milk-Based Formula: This formula is based on high-quality milk, carefully selected to provide a balanced and easily digestible source of nutrition for your baby.
• DHA and Omega-3: Aptamil Stage 1 is enriched with DHA (Docosahexaenoic Acid) and Omega-3 fatty acids, essential nutrients that support brain and visual development in infants.
• Prebiotics: Prebiotics in the formula help promote a healthy gut microbiome in your baby, supporting their digestive health and overall immune system.
• Nutritionally Balanced: Aptamil Stage 1 is formulated to meet the nutritional needs of your growing infant and provides essential vitamins and minerals necessary for their development.
• Convenient Packaging: The 1.76-pound (800g) pack of Aptamil Stage 1 ensures you have an ample supply to meet your baby's nutritional needs.
• Trusted Brand: Aptamil is a well-known and trusted brand in Europe, known for its commitment to producing high-quality infant formulas backed by scientific research.
• Easy Preparation: The formula is easy to prepare, following the instructions on the packaging, making it a convenient choice for busy parents.

Ensure you consult with your pediatrician or healthcare provider before introducing any formula to your baby's diet to ensure it's suitable for their specific needs and dietary requirements.

NOTE: EXP: 25-FEB-2024